Herbert W. Virgin IV
Net Worth

Last updated:

What is Herbert W. Virgin IV net worth?

The estimated net worth of Dr. Herbert W. Virgin IV is at least $8,256,564 as of 9 Aug 2022. He owns shares worth $763,020 as insider, has earned $1,943,544 from insider trading and has received compensation worth at least $5,550,000 in Vir Biotechnology, Inc..

What is the salary of Herbert W. Virgin IV?

Dr. Herbert W. Virgin IV salary is $1,110,000 per year as Executive Vice President of Research & Chief Scientific Officer in Vir Biotechnology, Inc..

How old is Herbert W. Virgin IV?

Dr. Herbert W. Virgin IV is 69 years old, born in 1956.

What stocks does Herbert W. Virgin IV currently own?

As insider, Dr. Herbert W. Virgin IV owns shares in one company:

Company Title Shares Price per share Total value
Vir Biotechnology, Inc. (VIR) Executive Vice President of Research & Chief Scientific Officer 175,407 $4.35 $763,020

What does Vir Biotechnology, Inc. do?

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Herbert W. Virgin IV insider trading

Vir Biotechnology, Inc.

Dr. Herbert W. Virgin IV has made 58 insider trades between 2020-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 70,177 units of VIR stock on 9 Aug 2022. As of 9 Aug 2022 he still owns at least 175,407 units of VIR stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 70,177 $1.53 $107,371
Option
Stock Option (Right to Buy) 7,916 $10.4 $82,287
Option
Common Stock 7,916 $10.4 $82,287
Option
Stock Option (Right to Buy) 70,177 $1.53 $107,371
Option
Common Stock 9,000 $1.53 $13,770
Option
Stock Option (Right to Buy) 9,000 $1.53 $13,770
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $30 $41,250
Sale
Common Stock 2,293 $31.93 $73,218
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $33.94 $46,668
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $32.46 $44,633
Option
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $35.1 $48,263
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $39.95 $54,931
Sale
Common Stock 2,750 $50 $137,500
Option
Common Stock 2,750 $1.53 $4,208
Option
Stock Option (Right to Buy) 4,125 $1.53 $6,311
Sale
Common Stock 1,375 $45.88 $63,085
Option
Common Stock 1,375 $1.53 $2,104
Option
Common Stock 15,125 $1.53 $23,141
Option
Stock Option (Right to Buy) 15,125 $1.53 $23,141
Sale
Common Stock 15,125 $47.8 $722,975
Sale
Common Stock 1,375 $32.67 $44,921
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $36.94 $50,793
Option
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $38.87 $53,446
Option
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $33.75 $46,406
Option
Common Stock 1,375 $1.53 $2,104
Option
Common Stock 8,000 $1.53 $12,240
Option
Stock Option (Right to Buy) 8,000 $1.53 $12,240
Option
Common Stock 4,125 $1.53 $6,311
Option
Stock Option (Right to Buy) 4,125 $1.53 $6,311
Sale
Common Stock 4,125 $50 $206,250
Option
Stock Option (Right to Buy) 4,125 $1.53 $6,311
Sale
Common Stock 4,125 $49.5 $204,188
Option
Common Stock 4,125 $1.53 $6,311
Option
Common Stock 2,750 $1.53 $4,208
Sale
Common Stock 2,750 $1.53 $4,208
Option
Stock Option (Right to Buy) 2,750 $1.53 $4,208
Sale
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Sale
Common Stock 13,750 $1.53 $21,038
Option
Stock Option (Right to Buy) 13,750 $1.53 $21,038
Option
Common Stock 13,750 $1.53 $21,038
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $1.53 $2,104
Option
Common Stock 1,375 N/A N/A
Sale
Common Stock 1,375 N/A N/A
Option
Stock Option (Right to Buy) 1,375 N/A N/A
Option
Common Stock 1,375 N/A N/A
Option
Stock Option (Right to Buy) 1,375 N/A N/A
Sale
Common Stock 1,375 N/A N/A
Option
Common Stock 8,000 N/A N/A
Option
Stock Option (Right to Buy) 8,000 N/A N/A
Option
Common Stock 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 $1.53 $2,104
Option
Common Stock 1,375 $1.53 $2,104
Sale
Common Stock 1,375 $1.53 $2,104
Option
Stock Option (Right to Buy) 1,375 N/A N/A
Option
Common Stock 1,375 N/A N/A
Sale
Common Stock 1,375 N/A N/A
Option
Common Stock 7,900 N/A N/A
Option
Stock Option (Right to Buy) 7,900 N/A N/A
Sale
Common Stock 7,900 N/A N/A
Option
Stock Option (Right to Buy) 2,340 $1.53 $3,580
Sale
Common Stock 2,340 $1.53 $3,580
Option
Common Stock 2,340 $1.53 $3,580
Option
Common Stock 3,500 $1.53 $5,355
Option
Stock Option (Right to Buy) 3,500 $1.53 $5,355
Option
Stock Option (Right to Buy) 5,560 $1.53 $8,507
Option
Common Stock 5,560 $1.53 $8,507
Sale
Common Stock 5,560 $1.53 $8,507
Option
Common Stock 14,000 $1.53 $21,420
Option
Stock Option (Right to Buy) 14,000 $1.53 $21,420
Option
Stock Option (Right to Buy) 7,900 N/A N/A
Option
Common Stock 7,900 N/A N/A
Sale
Common Stock 7,900 N/A N/A
Option
Stock Option (Right to Buy) 2,340 $1.53 $3,580
Sale
Common Stock 2,340 $1.53 $3,580
Option
Common Stock 2,340 $1.53 $3,580
Sale
Common Stock 5,560 N/A N/A
Option
Stock Option (Right to Buy) 5,560 N/A N/A
Option
Common Stock 5,560 N/A N/A
Option
Common Stock 18,900 N/A N/A
Option
Stock Option (Right to Buy) 18,900 N/A N/A
Sale
Common Stock 7,900 N/A N/A
Option
Stock Option (Right to Buy) 7,900 $1.53 $12,087
Sale
Common Stock 7,900 $1.53 $12,087
Option
Common Stock 7,900 N/A N/A
Sale
Common Stock 31,300 N/A N/A
Option
Stock Option (Right to Buy) 31,300 $1.53 $47,889
Option
Common Stock 31,300 N/A N/A
Option
Stock Option (Right to Buy) 10,530 N/A N/A
Option
Common Stock 10,530 $1.53 $16,111
Sale
Common Stock 10,530 $1.53 $16,111
Option
Stock Option (Right to Buy) 3,805 $1.53 $5,822
Sale
Common Stock 3,805 $1.53 $5,822
Option
Common Stock 3,805 N/A N/A
Option
Stock Option (Right to Buy) 9,500 $1.53 $14,535
Option
Common Stock 9,500 N/A N/A
Sale
Common Stock 3,805 $1.53 $5,822
Option
Common Stock 3,805 N/A N/A
Option
Stock Option (Right to Buy) 3,805 $1.53 $5,822
Sale
Common Stock 3,805 N/A N/A
Option
Common Stock 3,805 $1.53 $5,822
Option
Stock Option (Right to Buy) 3,805 $1.53 $5,822
Option
Stock Option (Right to Buy) 2,930 $1.53 $4,483
Sale
Common Stock 2,930 $1.53 $4,483
Option
Common Stock 2,930 $1.53 $4,483
Option
Common Stock 2,340 $1.53 $3,580
Sale
Common Stock 2,340 $1.53 $3,580
Option
Stock Option (Right to Buy) 2,340 $1.53 $3,580
Option
Stock Option (Right to Buy) 2,340 $1.53 $3,580
Option
Common Stock 2,340 N/A N/A
Sale
Common Stock 2,340 $1.53 $3,580
Sale
Common Stock 3,805 N/A N/A
Option
Common Stock 3,805 N/A N/A
Option
Stock Option (Right to Buy) 3,805 N/A N/A
Sale
Common Stock 5,560 N/A N/A
Option
Common Stock 5,560 N/A N/A
Option
Stock Option (Right to Buy) 5,560 N/A N/A
Option
Common Stock 3,510 N/A N/A
Option
Stock Option (Right to Buy) 3,510 N/A N/A
Sale
Common Stock 3,510 N/A N/A
Option
Common Stock 3,700 N/A N/A
Option
Stock Option (Right to Buy) 3,700 N/A N/A
Option
Common Stock 3,805 N/A N/A
Option
Stock Option (Right to Buy) 3,805 N/A N/A
Sale
Common Stock 3,805 N/A N/A
Sale
Common Stock 3,805 N/A N/A
Option
Common Stock 3,805 N/A N/A
Option
Stock Option (Right to Buy) 3,805 N/A N/A
Sale
Common Stock 5,560 N/A N/A
Option
Stock Option (Right to Buy) 25,560 N/A N/A
Option
Common Stock 25,560 N/A N/A
Option
Common Stock 7,900 N/A N/A
Sale
Common Stock 7,900 N/A N/A
Option
Stock Option (Right to Buy) 7,900 N/A N/A
Sale
Common Stock 7,900 N/A N/A
Option
Stock Option (Right to Buy) 7,900 N/A N/A
Option
Common Stock 7,900 N/A N/A
Option
Common Stock 7,900 N/A N/A
Sale
Common Stock 7,900 N/A N/A
Option
Stock Option (Right to Buy) 7,900 N/A N/A
Option
Common Stock 9,360 N/A N/A
Sale
Common Stock 9,360 N/A N/A
Option
Stock Option (Right to Buy) 9,360 N/A N/A
Option
Stock Option (Right to Buy) 5,560 N/A N/A
Sale
Common Stock 5,560 N/A N/A
Option
Common Stock 5,560 N/A N/A
Option
Common Stock 3,510 N/A N/A
Option
Stock Option (Right to Buy) 3,510 N/A N/A
Sale
Common Stock 3,510 N/A N/A
Option
Stock Option (Right to Buy) 3,805 N/A N/A
Sale
Common Stock 3,805 N/A N/A
Option
Common Stock 3,805 N/A N/A
Sale
Common Stock 3,805 N/A N/A
Option
Common Stock 3,805 N/A N/A
Option
Stock Option (Right to Buy) 3,805 N/A N/A
Sale
Common Stock 1,755 N/A N/A
Option
Stock Option (Right to Buy) 1,755 N/A N/A
Option
Common Stock 1,755 N/A N/A
Option
Common Stock 3,805 N/A N/A
Sale
Common Stock 3,805 N/A N/A
Option
Stock Option (Right to Buy) 3,805 N/A N/A

Vir Biotechnology key executives

Vir Biotechnology, Inc. executives and other stock owners filed with the SEC: